Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Enochian Biosciences Inc (NQ: ENOB )

0.8200 -0.0001 (-0.01%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 62,486
Open 0.8500
Bid (Size) 0.7900 (3)
Ask (Size) 1.050 (4)
Prev. Close 0.8201
Today's Range 0.7750 - 0.8784
52wk Range 0.7238 - 4.200
Shares Outstanding 58,283,591
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Enochian BioSciences’ CEO Letter to Shareholders
Turning the Page; A Promising Future 
From Enochian BioSciences, Inc.
Via GlobeNewswire
Enochian BioSciences Announces a Scientific Presentation of Proof-of-Concept Studies for a Potential Therapy for Cancers with a Poor Life Expectancy by a Leading Researcher
From Enochian BioSciences, Inc.
Via GlobeNewswire

Performance

YTD
-26.79%
-26.79%
1 Month
-31.67%
-31.67%
3 Month
-28.70%
-28.70%
6 Month
-31.09%
-31.09%
1 Year
-77.96%
-77.96%

More News

Read More
Enochian BioSciences Achieves Full Compliance with NASDAQ Filing Requirements
From Enochian BioSciences, Inc.
Via GlobeNewswire
Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended December 31, 2022
From Enochian BioSciences, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended September 30, 2022
From Enochian BioSciences, Inc.
Via GlobeNewswire
NASDAQ:ENOB Long-Term Investor Notice: Investigation over Potential Wrongdoing at Enochian Biosciences, Inc.
Via SBWire
Enochian BioSciences Forges Ahead With Focused Approach, Promising Future
From Enochian BioSciences, Inc.
Via GlobeNewswire
Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Annual Report on Form 10-K
From Enochian BioSciences, Inc.
Via GlobeNewswire
Enochian BioSciences Awarded U.S. Patent For Its Promising Oncology Platform
From Enochian BioSciences, Inc.
Via GlobeNewswire
ENOCHIAN DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Enochian Biosciences, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Enochian Biosciences, Inc. (ENOB)
From The Law Offices of Frank R. Cruz
Via Business Wire
ENOB FINAL DEADLINE MONDAY: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Enochian BioSciences, Inc. Investors to Secure Counsel Before Important September 26 Deadline in Securities Class Action - ENOB
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
ENOB FINAL DEADLINE NOTICE: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Enochian BioSciences, Inc. Investors to Secure Counsel Before Important September 26 Deadline in Securities Class Action - ENOB
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Why ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Adobe Is Trading Lower By 17%, Here Are 49 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why NeuroBo Pharmaceuticals Is Trading Higher By Around 55%; Here Are 25 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Enochian BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ENOB
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Enochian BioSciences, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ENOB
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Enochian Biosciences, Inc. (ENOB) Investors and Encourages Investors to Contact the Firm Before September 26, 2022
From Kirby McInerney LLP
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.